Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe
-
THOR Industries Announces Participation in Upcoming Investor Conferences
-
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
-
Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
-
Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results
-
Exodus Reports Fourth Quarter and Full Year 2024 Results, Provides Preliminary First Quarter 2025 Highlights
-
FEMSA Announces the date for its Annual Shareholders’ Meeting
-
Greenlight Capital Re, Ltd. Schedules Fourth Quarter and Full Year 2024 Financial Results and Conference Call
-
Armada Hoffler Announces Appointment of Jennifer Boykin to the Company’s Board of Directors
-
Microchip Technology to Present at the Raymond James 46th Annual Investors Conference
-
XAI Madison Equity Premium Income Fund Declares its Quarterly Distribution of $0.18 per Share – Fund to Change Distribution Frequency
-
XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.077 per Share
-
Employers Holdings, Inc. Appoints Marvin Pestcoe to Board of Directors
-
Acuity Brands to Announce Fiscal 2025 Second-Quarter Results on April 3, 2025
-
Whitestone REIT Reports Fourth Quarter and Full Year 2024 Results
-
Meiwu Technology Company Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
-
Lifetime Brands Announces Participation in Upcoming Investor Conferences
-
Earlyworks Co., Ltd. Reports Financial and Operational Performance for the Six Months Ended October 31, 2024
-
Tenaya Therapeutics Announces Proposed Public Offering
-
Gencor Announces Preliminary Unaudited Results
-
ThredUp Announces Fourth Quarter and Full Year 2024 Results
-
Dave Reports Fourth Quarter & Full Year 2024 Financial Results
-
Rigetti Computing to Participate in Fireside Chat at Cantor Global Technology Conference
-
NeuroPace to Present at the Leerink Partners Global Healthcare Conference
-
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
-
Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference
-
CTO Realty Growth Announces Acquisition of Lifestyle Center in Atlanta, Georgia for $79.8 Million
-
Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results
-
Pool Corporation to Participate in the Loop Capital Markets 2025 Investor Conference
-
LifeVantage Announces Launch of LV360 and Evolve Compensation Plan in Philippines, Taiwan, Hong Kong, and Singapore Markets
-
The Ensign Group Continues Growth in Arizona
-
The Ensign Group Grows in Washington; Adds Its First Operations in Alaska and Oregon
-
Larimar Therapeutics to Present at the Leerink Partners Global Healthcare Conference
-
Jamf announces intent to acquire Identity Automation to bring identity and device management together in one powerful, secure platform
-
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results
-
Fifth Era Acquisition Corp I Completes $230,000,000 Initial Public Offering
-
89bio to Participate in the Leerink Partners Global Healthcare Conference
-
Synergy CHC to Attend 37th Annual ROTH Conference
-
ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
-
Parsons Unveils Advanced ZEUS Directed Energy System on Next-Gen JLTV Platform, Enhancing Military Capability
-
Jamf announces intent to acquire Identity Automation to bring identity and device management together in one powerful, secure platform
-
Astera Labs Appoints Dr. Craig Barratt to Board of Directors
-
GigaCloud Technology Inc Announces Fourth Quarter and Year Ended December 31, 2024 Financial Results
-
Lesaka to Host an Investor Day on March 31, 2025
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Venus Concept to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025
-
Amwell makes inducement grant
-
ACM Research Announces Qualification of High-Temperature SPM Tool for Customer in China
